Kinnate Biopharma Overview

Kinnate Biopharma Research & Development

Research & Development expenses for KNTE.

Quarterly R&D Expenses

$13.37M

↓ 46.92% YoY

As of Dec 31, 2023

Annual R&D Expenses (TTM)

$90.77M

↑ 2.97% YoY

Trailing 12 months ending Dec 31, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin